{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:40:58Z","timestamp":1770986458309,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008696","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a significant health problem worldwide with poor prognosis. Drug repositioning represents a profitable strategy to accelerate drug discovery in the treatment of HCC. In this study, we developed a new approach for predicting therapeutic drugs for HCC based on tissue-specific pathways and identified three newly predicted drugs that are likely to be therapeutic drugs for the treatment of HCC. We validated these predicted drugs by analyzing their overlapping drug indications reported in PubMed literature. By using the cancer cell line data in the database, we constructed a Connectivity Map (CMap) profile similarity analysis and KEGG enrichment analysis on their related genes. By experimental validation, we found securinine and ajmaline significantly inhibited cell viability of HCC cells and induced apoptosis. Among them, securinine has lower toxicity to normal liver cell line, which is worthy of further research. Our results suggested that the proposed approach was effective and accurate for discovering novel therapeutic options for HCC. This method also could be used to indicate unmarked drug-disease associations in the Comparative Toxicogenomics Database. Meanwhile, our method could also be applied to predict the potential drugs for other types of tumors by changing the database.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1008696","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T02:42:07Z","timestamp":1612924927000},"page":"e1008696","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-3332","authenticated-orcid":true,"given":"Liang","family":"Yu","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0650-2170","authenticated-orcid":true,"given":"Meng","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Fengdan","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Fei","family":"Xie","sequence":"additional","affiliation":[]},{"given":"Lin","family":"Gao","sequence":"additional","affiliation":[]},{"given":"Xiangzhi","family":"Li","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"issue":"6","key":"pcbi.1008696.ref001","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"pcbi.1008696.ref002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrd1384","article-title":"Opinion: Prospects for productivity","volume":"3","author":"B Booth","year":"2004","journal-title":"Nature Reviews Drug Discovery"},{"issue":"5","key":"pcbi.1008696.ref003","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1067\/mcp.2001.115132","article-title":"New drug development in the United States from 1963 to 1999","volume":"69","author":"JA DiMasi","year":"2001","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"9","key":"pcbi.1008696.ref004","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009\u20132018","volume":"323","author":"OJ Wouters","year":"2020","journal-title":"Jama"},{"issue":"8","key":"pcbi.1008696.ref005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"TT Ashburn","year":"2004","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"pcbi.1008696.ref006","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"AW Lucky","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"pcbi.1008696.ref007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1464-410X.1996.10220.x","article-title":"Sildenafil, a novel effective oral therapy for male erectile dysfunction","volume":"78","author":"M Boolell","year":"1996","journal-title":"BJU International"},{"issue":"1","key":"pcbi.1008696.ref008","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12032-012-0433-3","article-title":"Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole","volume":"30","author":"G Kleinotiene","year":"2013","journal-title":"Medical Oncology"},{"issue":"12","key":"pcbi.1008696.ref009","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe","volume":"74","author":"H Feldman","year":"2010","journal-title":"Neurology"},{"key":"pcbi.1008696.ref010","article-title":"Identifying liver cancer-related enhancer SNPs by integrating GWAS and histone modification ChIP-seq data","volume":"2016","author":"T Zhang","year":"2016","journal-title":"BioMed Research International"},{"issue":"4","key":"pcbi.1008696.ref011","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt.2151","article-title":"Use of genome-wide association studies for drug repositioning","volume":"30","author":"P Sanseau","year":"2012","journal-title":"Nature Biotechnology"},{"issue":"11","key":"pcbi.1008696.ref012","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrg3031","article-title":"Exome sequencing as a tool for Mendelian disease gene discovery","volume":"12","author":"MJ Bamshad","year":"2011","journal-title":"Nature Reviews Genetics"},{"issue":"23","key":"pcbi.1008696.ref013","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.scib.2017.11.012","article-title":"The histone acetyltransferase MOF is required for the cellular stress response","volume":"62","author":"Y Yang","year":"2017","journal-title":"Science Bulletin"},{"issue":"17","key":"pcbi.1008696.ref014","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1007\/s11434-012-4982-9","article-title":"A pathway profile-based method for drug repositioning","volume":"57","author":"H Ye","year":"2012","journal-title":"Chinese Science Bulletin"},{"issue":"1","key":"pcbi.1008696.ref015","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1364","article-title":"Computational approaches for the identification of cancer genes and pathways","volume":"9","author":"CM Dimitrakopoulos","year":"2017","journal-title":"Wiley interdisciplinary reviews Systems biology and medicine"},{"issue":"suppl_1","key":"pcbi.1008696.ref016","doi-asserted-by":"crossref","first-page":"D355","DOI":"10.1093\/nar\/gkp896","article-title":"KEGG for representation and analysis of molecular networks involving diseases and drugs","volume":"38","author":"M Kanehisa","year":"2009","journal-title":"Nucleic Acids Research"},{"issue":"16","key":"pcbi.1008696.ref017","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2105-14-S16-S3","article-title":"Pathway-based drug repositioning using causal inference","volume":"14","author":"J Li","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"pcbi.1008696.ref018","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12918-016-0364-2","article-title":"The extraction of drug-disease correlations based on module distance in incomplete human interactome","volume":"10","author":"L Yu","year":"2016","journal-title":"BMC Systems Biology"},{"issue":"2","key":"pcbi.1008696.ref019","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1755-8794-8-S2-S2","article-title":"Inferring drug-disease associations based on known protein complexes","volume":"8","author":"L Yu","year":"2015","journal-title":"BMC Medical Genomics"},{"issue":"4","key":"pcbi.1008696.ref020","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1109\/TCBB.2016.2550453","article-title":"Prediction of novel drugs for hepatocellular carcinoma based on multi-source random walk","volume":"14","author":"L Yu","year":"2017","journal-title":"IEEE\/ACM Transactions on Computational Biology and Bioinformatics"},{"issue":"8","key":"pcbi.1008696.ref021","doi-asserted-by":"crossref","first-page":"971","DOI":"10.7150\/ijbs.23350","article-title":"Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity","volume":"14","author":"L Yu","year":"2018","journal-title":"International Journal of Biological Sciences"},{"issue":"1","key":"pcbi.1008696.ref022","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","article-title":"MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer","volume":"32","author":"SK Shukla","year":"2017","journal-title":"Cancer cell"},{"issue":"4","key":"pcbi.1008696.ref023","article-title":"Pathway analyses and understanding disease associations","volume":"1","author":"Y Liu","year":"2013","journal-title":"Current genetic medicine reports"},{"issue":"5795","key":"pcbi.1008696.ref024","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"J Lamb","year":"2006","journal-title":"Science"},{"issue":"D1","key":"pcbi.1008696.ref025","doi-asserted-by":"crossref","first-page":"D914","DOI":"10.1093\/nar\/gku935","article-title":"The Comparative Toxicogenomics Database\u2019s 10th year anniversary: update 2015","volume":"43","author":"AP Davis","year":"2014","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"pcbi.1008696.ref026","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"R Edgar","year":"2002","journal-title":"Nucleic Acids Research"},{"key":"pcbi.1008696.ref027","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1186\/1471-2164-14-736","article-title":"Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC.","volume":"14","author":"HW Wang","year":"2013","journal-title":"BMC genomics"},{"issue":"1","key":"pcbi.1008696.ref028","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/nar\/30.1.52","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders.","volume":"30","author":"A Hamosh","year":"2002","journal-title":"Nucleic Acids Research"},{"issue":"suppl_1","key":"pcbi.1008696.ref029","first-page":"D514","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"33","author":"A Hamosh","year":"2005","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"pcbi.1008696.ref030","first-page":"819","article-title":"EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma","volume":"79","author":"Q Dong","year":"2019"},{"issue":"8","key":"pcbi.1008696.ref031","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/liv.13055","article-title":"Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2\/mTORC1 cascade","volume":"36","author":"C Wang","year":"2016","journal-title":"Liver Int"},{"issue":"6","key":"pcbi.1008696.ref032","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","article-title":"The genomic landscape of hepatoblastoma and their progenies with HCC-like features","volume":"61","author":"M Eichenm\u00fcller","year":"2014","journal-title":"Journal of hepatology"},{"issue":"4","key":"pcbi.1008696.ref033","first-page":"2299","article-title":"Expression and prognostic significance of insulin-like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization","volume":"41","author":"A Lautem","year":"2019","journal-title":"Oncology reports"},{"issue":"3","key":"pcbi.1008696.ref034","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2017.08.010","article-title":"A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development","volume":"32","author":"Y Boege","year":"2017","journal-title":"Cancer cell"},{"issue":"5","key":"pcbi.1008696.ref035","first-page":"891","article-title":"Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene","volume":"10","author":"Y Fujiwara","year":"1995","journal-title":"Oncogene"},{"issue":"24","key":"pcbi.1008696.ref036","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1158\/0008-5472.CAN-14-1446","article-title":"MDM2-p53 pathway in hepatocellular carcinoma","volume":"74","author":"X Meng","year":"2014","journal-title":"Cancer research"},{"issue":"6","key":"pcbi.1008696.ref037","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2017.12.018","article-title":"AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of \u03b2-catenin activation","volume":"68","author":"S Abitbol","year":"2018","journal-title":"Journal of hepatology"},{"issue":"6","key":"pcbi.1008696.ref038","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3259","article-title":"Understanding multicellular function and disease with human tissue-specific networks","volume":"47","author":"CS Greene","year":"2015","journal-title":"Nature Genetics"},{"issue":"2","key":"pcbi.1008696.ref039","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/biostatistics\/kxm030","article-title":"Small-sample estimation of negative binomial dispersion, with applications to SAGE data","volume":"9","author":"MD Robinson","year":"2007","journal-title":"Biostatistics"},{"issue":"12","key":"pcbi.1008696.ref040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biology"},{"key":"pcbi.1008696.ref041","doi-asserted-by":"crossref","DOI":"10.1002\/9780470488065","volume-title":"Biomolecular networks: methods and applications in systems biology","author":"L Chen","year":"2009"},{"key":"pcbi.1008696.ref042","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-84996-214-8","volume-title":"Modeling biomolecular networks in cells: structures and dynamics","author":"L Chen","year":"2010"},{"issue":"1","key":"pcbi.1008696.ref043","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"DW Huang","year":"2008","journal-title":"Nature Protocols"},{"issue":"1","key":"pcbi.1008696.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"W Huang da","year":"2009","journal-title":"Nucleic acids research"},{"issue":"3","key":"pcbi.1008696.ref045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0167-7152(97)00020-5","article-title":"A multivariate Kolmogorov-Smirnov test of goodness of fit.","volume":"35","author":"A Justel","year":"1997","journal-title":"Statistics & Probability Letters"},{"issue":"7","key":"pcbi.1008696.ref046","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"pcbi.1008696.ref047","first-page":"7","article-title":"Result of application of securinine in acute poliomyelitis","volume":"21","author":"G. Buravtseva","year":"1958","journal-title":"Farmakologiia I Toksikologiia"},{"issue":"1","key":"pcbi.1008696.ref048","first-page":"36","article-title":"From Asia securinine\u2014a central nervous stimulant is used in treatment of amytrophic lateral sclerosis","volume":"76","author":"R Copperman","year":"1973","journal-title":"Pennsylvania Medicine."},{"issue":"3","key":"pcbi.1008696.ref049","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.1974.03230280016013","volume":"228","author":"R Copperman","year":"1974","journal-title":"Securinine. JAMA"},{"issue":"1","key":"pcbi.1008696.ref050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(85)90014-9","article-title":"Securinine alkaloids: a new class of GABA receptor antagonist","volume":"330","author":"J Beutler","year":"1985","journal-title":"Brain Research"},{"issue":"21","key":"pcbi.1008696.ref051","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3748\/wjg.v18.i21.2704","article-title":"GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit","volume":"18","author":"Y-H Li","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"pcbi.1008696.ref052","first-page":"1","article-title":"Monoamine oxidase inhibition by isocarboxazid","volume":"135","author":"MA Schwartz","year":"1962","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"9","key":"pcbi.1008696.ref053","doi-asserted-by":"crossref","first-page":"e104271","DOI":"10.1371\/journal.pone.0104271","article-title":"Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes","volume":"9","author":"RR Gordon","year":"2014","journal-title":"PloS one"},{"key":"pcbi.1008696.ref054","article-title":"Chronic hyponatremia causes neurologic and psychologic impairments","author":"H Fujisawa","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"pcbi.1008696.ref055","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"CT Hensley","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"issue":"2B","key":"pcbi.1008696.ref056","first-page":"1249","article-title":"Phase I clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis","volume":"20","author":"B Daniele","year":"2000","journal-title":"Anticancer Research"},{"issue":"17","key":"pcbi.1008696.ref057","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1001\/jama.283.17.2228","article-title":"Withdrawal of Troglitazone and Cisapride","volume":"283","author":"JE Henney","year":"2000","journal-title":"Jama"},{"issue":"1","key":"pcbi.1008696.ref058","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/hep.20994","article-title":"Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo","volume":"43","author":"J Yu","year":"2006","journal-title":"Hepatology"},{"key":"pcbi.1008696.ref059","article-title":"The Merck Index, an encyclopedia of chemical drug, and biologicals","author":"S. Budavari","year":"1989","journal-title":"Merck"},{"issue":"2","key":"pcbi.1008696.ref060","first-page":"1515","article-title":"Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1","volume":"8","author":"X Huang","year":"2015","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"1","key":"pcbi.1008696.ref061","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3835(98)00388-7","article-title":"Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines","volume":"136","author":"S Gagandeep","year":"1999","journal-title":"Cancer Letters"},{"issue":"3\u20134","key":"pcbi.1008696.ref062","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000354585","article-title":"Molecular pathways and functional analysis of miRNA expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells","volume":"92","author":"H Yan","year":"2013","journal-title":"Pharmacology"},{"issue":"1","key":"pcbi.1008696.ref063","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3892\/ol.2015.3242","article-title":"Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy","volume":"10","author":"L Chen","year":"2015","journal-title":"Oncology Letters"},{"issue":"1","key":"pcbi.1008696.ref064","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/bjc.1998.438","article-title":"Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients","volume":"78","author":"Y Chao","year":"1998","journal-title":"British Journal of Cancer"},{"issue":"5","key":"pcbi.1008696.ref065","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4103\/0253-7613.100384","article-title":"Nimesulide inhibits the proliferation of HepG2 by up-regulation of Smad4","volume":"44","author":"S Yang","year":"2012","journal-title":"Indian Journal of Pharmacology"},{"key":"pcbi.1008696.ref066","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/ncomms3508","article-title":"Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma","volume":"4","author":"R Ma","year":"2013","journal-title":"Nature Communications"},{"issue":"2","key":"pcbi.1008696.ref067","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0029-1214377","article-title":"Role of alcohol in liver carcinogenesis","volume":"29","author":"IH McKillop","year":"2009","journal-title":"Semin Liver Dis"},{"issue":"16","key":"pcbi.1008696.ref068","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","article-title":"Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics","volume":"73","author":"Q Huang","year":"2013","journal-title":"Cancer Research"},{"issue":"7","key":"pcbi.1008696.ref069","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.ejca.2008.11.007","article-title":"Common genetic variations of the cytochrome P450 1A1 gene and risk of hepatocellular carcinoma in a Chinese population","volume":"45","author":"R Li","year":"2009","journal-title":"European Journal of Cancer"},{"issue":"5","key":"pcbi.1008696.ref070","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","article-title":"Molecular pathways: beta-adrenergic signaling in cancer","volume":"18","author":"SW Cole","year":"2012","journal-title":"Clinical Cancer Research"},{"key":"pcbi.1008696.ref071","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/CLEP.S33695","article-title":"Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint","volume":"4","author":"PJ Fitzgerald","year":"2012","journal-title":"Clinical Epidemiology"},{"issue":"2","key":"pcbi.1008696.ref072","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.24063","article-title":"Is norepinephrine an etiological factor in some types of cancer?","volume":"124","author":"PJ Fitzgerald","year":"2009","journal-title":"International Journal of Cancer"},{"issue":"5","key":"pcbi.1008696.ref073","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI40802","article-title":"Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis","volume":"120","author":"AK Sood","year":"2010","journal-title":"The Journal of clinical investigation"},{"issue":"2","key":"pcbi.1008696.ref074","first-page":"369","article-title":"Stress hormone-mediated invasion of ovarian cancer cells. Clinical cancer research: an official journal of the","volume":"12","author":"AK Sood","year":"2006","journal-title":"American Association for Cancer Research"},{"issue":"8","key":"pcbi.1008696.ref075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"PH Thaker","year":"2006","journal-title":"Nature medicine"},{"key":"pcbi.1008696.ref076","doi-asserted-by":"crossref","first-page":"111726","DOI":"10.1016\/j.ejmech.2019.111726","article-title":"Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance","volume":"183","author":"W Hou","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"20","key":"pcbi.1008696.ref077","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1021\/jo000260z","article-title":"Total syntheses of the Securinega alkaloids (+)-14,15-dihydronorsecurinine, (-)-norsecurinine, and phyllanthine","volume":"65","author":"G Han","year":"2000","journal-title":"J Org Chem"},{"key":"pcbi.1008696.ref078","first-page":"234","article-title":"Toxicity of securinine and comparison with strychnine","volume":"4","author":"HY Chang","year":"1974","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"pcbi.1008696.ref079","author":"H-M Chang","year":"2014","journal-title":"Pharmacology and Applications of Chinese Materia Medica: (Volume I): World Scientific"},{"issue":"1","key":"pcbi.1008696.ref080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbadis.2016.10.019","article-title":"Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase","volume":"1863","author":"J Zhang","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"pcbi.1008696.ref081","article-title":"L-securinine inhibits cell growth and metastasis of human androgen-independent prostate cancer DU145 cells via regulating mitochondrial and AGTR1\/MEK\/ERK\/STAT3\/PAX2 apoptotic pathways","author":"D Zhang","year":"2019","journal-title":"Bioscience reports"},{"issue":"4","key":"pcbi.1008696.ref082","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.3892\/ol.2017.6693","article-title":"L-securinine inhibits the proliferation of A549 lung cancer cells and promotes DKK1 promoter methylation","volume":"14","author":"S Han","year":"2017","journal-title":"Oncol Lett"},{"key":"pcbi.1008696.ref083","doi-asserted-by":"crossref","DOI":"10.1142\/0284","author":"H-M Chang","year":"1986","journal-title":"Pharmacology and applications of Chinese materia medica: World Scientific"},{"key":"pcbi.1008696.ref084","first-page":"1729135","article-title":"Proapoptotic Role of Potassium Ions in Liver Cells","volume":"2016","author":"Z Xia","year":"2016","journal-title":"Biomed Res Int"},{"issue":"1","key":"pcbi.1008696.ref085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjp.0707198","article-title":"Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid","volume":"151","author":"JS Isenberg","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"34","key":"pcbi.1008696.ref086","doi-asserted-by":"crossref","first-page":"21342","DOI":"10.1039\/C7RA02113E","article-title":"Melatonin enhances the anti-tumor effect of sorafenib via AKT\/p27-mediated cell cycle arrest in hepatocarcinoma cell lines","volume":"7","author":"F Long","year":"2017","journal-title":"RSC advances"},{"issue":"18","key":"pcbi.1008696.ref087","doi-asserted-by":"crossref","first-page":"30464","DOI":"10.18632\/oncotarget.12826","article-title":"Hepatocellular carcinoma and antidepressants: a nationwide population-based study","volume":"8","author":"VC Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"pcbi.1008696.ref088","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3109\/02656736.2014.974694","article-title":"Tumour eradication using synchronous thermal ablation and Hsp90 chemotherapy with protein engineered triblock biopolymer-geldanamycin conjugates","volume":"30","author":"Y Chen","year":"2014","journal-title":"International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group"},{"key":"pcbi.1008696.ref089","volume-title":"Advanced engineering mathematics","author":"E. Kreyszig","year":"2010"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008696","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T18:38:17Z","timestamp":1614623897000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008696"}},"subtitle":[],"editor":[{"given":"James","family":"Gallo","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":89,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008696","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1008696","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,9]]}}}